Table 3.

Impact of treatment on the EAMQ (entire scale) in survivors

	Univariate			Multivariable
	Mean (SD)	95% CI	p-value	LS mean (SE)	95% CI	p-value
Age at evaluation, years	-	-	0.003	-	-	0.03
Age at diagnosis, years
<5	0.56 (0.27)	0.44-0.68	0.05	0.47 (0.08)	0.31-0.63	0.76
5-20	0.40 (0.32)	0.31-0.49		0.45 (0.05)	0.34-0.55
Sex
Male	0.40(0.33)	0.29-0.51	0.19	0.44 (0.06)	0.31-0.57	0.60
Female	0.50 (0.29)	0.40-0.59		0.48 (0.06)	0.35-0.61
Segmental radiation
Posterior fossa/spine
No	0.42 (0.34)	0.31-0.54	0.51	0.59 (0.09)	0.41-0.76	0.08
Yes	0.47 (0.28)	0.38-0.57		0.34 (0.09)	0.16-0.52
Temporal lobe
No	0.37(0.34)	0.25-0.50	0.10	0.36 (0.09)	0.18-0.55	0.09
Yes	0.50 (0.29)	0.41-0.58		0.56 (0.06)	0.44-0.68
Frontal cortex
No	0.38(0.33)	0.28-0.48	0.04	0.37(0.08)	0.21-0.52	0.17
Yes	0.53 (0.28)	0.43-0.63		0.56 (0.09)	0.37-0.74
Occipital/parietal lobe
No	0.42 (0.33)	0.32-0.52	0.40	0.48 (0.09)	0.29-0.66	0.81
Yes	0.48 (0.29)	0.38-0.59		0.44 (0.08)	0.29-0.60
Shunt placement
No	0.41 (0.30)	0.33-0.50	0.18	0.42 (0.06)	0.30-0.55	0.32
Yes	0.52(0.35)	0.37-0.66		0.50 (0.07)	0.37-0.63
Tumor type
Astrocytic	0.44 (0.33)	0.33-0.55	0.15	0.45 (0.06)	0.32-0.58	0.22
Medulloblastoma	0.56(0.23)	0.42-0.71		0.50(0.10)	0.31-0.70
Ependymoma	0.53 (0.30)	0.31-0.76		0.59(0.12)	0.35-0.83
Other	0.31(0.32)	0.14-0.49		0.30(0.10)	0.11-0.49
Chemotherapy
No	0.41 (0.32)	0.33-0.50	0.17	0.48 (0.07)	0.35-0.61	0.77
Yes	0.53 (0.29)	0.40-0.65		0.45 (0.08)	0.28-0.61